Drägerwerk AG's 2024 Financial Overview and 2025 Outlook

Drägerwerk AG & Co. KGaA has reported its preliminary financial results for 2024, indicating net sales slightly below expectations but earnings surpassing forecasts. The company's sales increased by 0.6%, reaching approximately EUR 3,373 million, which was marginally below the projected 1.0 to 3.0% growth. In contrast, earnings before interest and taxes (EBIT) rose to EUR 197 million, up by 19%, driven partly by one-time gains of EUR 22 million.

The safety division exhibited robust performance with a 5.1% increase in net sales, while the medical division experienced a 2.6% decline, primarily due to challenging market conditions in China. Overall, the gross margin improved from 43.3% to 45.0%.

For 2025, Dräger forecasts sales growth between 1.0 to 5.0% and an EBIT margin of 3.5 to 6.5%, aligning with its strategy to annually increase its EBIT margin.